|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM160586550 |
| 003 |
DE-627 |
| 005 |
20250207024153.0 |
| 007 |
tu |
| 008 |
231223s2006 xx ||||| 00| ||chi c |
| 028 |
5 |
2 |
|a pubmed25n0535.xml
|
| 035 |
|
|
|a (DE-627)NLM160586550
|
| 035 |
|
|
|a (NLM)16464390
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a chi
|
| 100 |
1 |
|
|a Li, Mao-qin
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Comparison of effects of low-dose dopamine and dobutamine in patients with nonoliguric renal failure
|
| 264 |
|
1 |
|c 2006
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 05.01.2010
|
| 500 |
|
|
|a Date Revised 21.11.2013
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a OBJECTIVE: To investigate the effects of low-dose dopamine and dobutamine on renal functioning patients with nonoliguric renal failure
|
| 520 |
|
|
|a METHODS: Twenty-nine hemodynamically stable patients with nonoliguric renal failure were enrolled to this study group. Each patient was given 5% glucose (control), dopamine or dobutamine in random order by means of an injection pump every 4 hours. The change in urine output, fractional excretion of sodium (FeNa) and creatinine clearance rate (CCr) were determined
|
| 520 |
|
|
|a RESULTS: Compared with control, urine volume, FeNa, and CCr were increased significantly after administration of dopamine, or dobutamine. Compared with dobutamine, dopamine could increase the urine output and the FeNa markedly, but there was no difference in CCr increase between dopamine and dobutamine
|
| 520 |
|
|
|a CONCLUSION: Dopamine or dobutamine treatment could significantly increase the urine output, FeNa, and CCr in patients with nonoliguric renal failure. Dopamine infusion markedly increases urine output and the FeNa, but there is no significantly difference in CCr between dopamine and dobutamine treatment
|
| 650 |
|
4 |
|a Comparative Study
|
| 650 |
|
4 |
|a English Abstract
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Randomized Controlled Trial
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
7 |
|a Dobutamine
|2 NLM
|
| 650 |
|
7 |
|a 3S12J47372
|2 NLM
|
| 650 |
|
7 |
|a Dopamine
|2 NLM
|
| 650 |
|
7 |
|a VTD58H1Z2X
|2 NLM
|
| 700 |
1 |
|
|a Shi, Zai-xiang
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Xu, Ji-yuan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhang, Zhou
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Lu, Fei
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Li, Lin
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
|d 1998
|g 18(2006), 1 vom: 07. Jan., Seite 51-3
|w (DE-627)NLM098227793
|x 1003-0603
|7 nnns
|
| 773 |
1 |
8 |
|g volume:18
|g year:2006
|g number:1
|g day:07
|g month:01
|g pages:51-3
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 18
|j 2006
|e 1
|b 07
|c 01
|h 51-3
|